Releaf in the Press: Highlights from the Medical Cannabis Sector 2024
2 min read
Lucy MacKinnon
Contents
Releaf has been at the forefront of the UK medical cannabis sector throughout 2024, garnering widespread media attention for its innovative patient-first approach and groundbreaking initiatives. From leading the conversation around accessibility to driving awareness of medical cannabis treatment options, Releaf has consistently made headlines, shaping the narrative of this rapidly evolving industry. With notable features in national publications and influential platforms, the spotlight on Releaf reflects its commitment to transforming lives and redefining the future of medical cannabis care in the UK.
The Times: June 2024
"Legal cannabis by post: inside the farm behind a British first"
Yahoo! News: November 2024
"Mum praises ‘miracle’ cannabis vape for ‘saving my son’ after mainstream treatments failed"
The Business Desk: October 2024
"Historic medical cannabis deal set to create jobs for Nottingham firm"
Manchester Evening News: November 2024
"Man fit the criteria for a 'cannabis card' after a quick Google"
MSN News: November 2024
"I'm a social worker and I use cannabis daily for health reasons' says 47-year-old Milton Keynes woman"
The Mirror: October 2024
"My son was wasting away, cannabis came to his rescue when doctors couldn’t"
The Daily Start: December 2024
"Releaf medical cannabis helped me reduce my pain and anxiety"
BBC Radio Cambridgeshire: December 2024
Share article
Did you like this article?
It is important to seek medical advice before starting any new treatments. The patient advisors at Releaf are available to provide expert advice and support. Alternatively, click here to book a consultation with one of our specialist doctors.
Elevate your wellness with medical cannabis
Get comprehensive care, convenience, and confidence with an all-in-one treatment plan.
Am I eligible?Authors
With five years of journalism and healthcare content creation under her belt, Lucy strives to improve medical cannabis awareness and access in the UK by producing high quality, credible content.
Editorial Policy
All of our articles are written by medical cannabis experts, guided by strict sourcing guidelines, and reference peer-reviewed studies and credible academic research. Our expert clinical team and compliance specialists provide valuable insights to ensure accuracy when required. Learn more in our editorial policy.
Need more help?
Further reading
Which rare conditions are treated at Releaf?
Next Friday, it’s Rare Disease Day, an event that takes place every year on the last day in February to act as a day of observance for rare conditions and the individuals they affect. This year, we’ve put together this blog to discuss which of the 83 conditions currently treated at Releaf are classed as rare, and, how frequently patients with these conditions are seen at our service.
Lucy MacKinnon
Managing medication side effects: Why more patients are exploring medical cannabis
Medical cannabis has been available in the UK since the 1st of November 2018. Since then, a growing number of patients have shown interest in medical cannabis as an alternative therapy - often due to the undesirable side effects of medications such as opioids, NSAIDs, and SSRIs. Could medical cannabis offer a safe and effective alternative to these conventional treatments?
Emily Ledger
Nursing a healthier future: How nurses are integral to medical cannabis treatment plans.
If you’re a Releaf patient, you may have already met Kim during one of your follow up consultations - but, if you’ve not yet had this pleasure, we’re pleased to introduce you to Kim Kaye, our Head of Nursing.
Lucy MacKinnon